Last reviewed · How we verify

Amoxicilli

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. · FDA-approved active Small molecule

At a glance

Generic nameAmoxicilli
SponsorShandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Target5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B, 5-hydroxytryptamine receptor 2C
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Approved indications

Common side effects

Serious adverse events

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results